iarc newsletter
Donate now
EN
19 April 2023

Protection from a Single Dose of HPV Vaccine

Protection from a Single Dose of HPV Vaccine Home

The International Agency for Research on Cancer (IARC) has released a new IARC Evidence Summary Brief, titled “Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy”. This report highlights promising recent developments, led by scientists from IARC and partners, that are huge steps to accelerate the elimination of cervical cancer as a threat to global public health.

This IARC Evidence Summary Brief is the fourth in a series of scientific Evidence Summary Briefs published by IARC to call attention to the findings of evidence-based studies in key aspects of cancer prevention.

Press release

IARC Press Release 333

Download PDF
Protection from a Single Dose of HPV Vaccine

Protection from a Single Dose of HPV Vaccine

A major public health impact from IARC studies of vaccine efficacy, IARC Evidence Summary Brief No. 4

Download PDF: English, French
Evidence Summary Briefs series

IARC Evidence Summary Briefs series

Read more



Close Reading Mode
UP